Upload Avatar (500 x 500)
Qing Ye
qingye1998@ustc.edu.cn
Chinese, English
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 1988.09—1993.07 Bachelor of Clinical Medicine: Wuhan University School of Medicine
  • 2000.09—2003.06 Master of Immunology: Wuhan University School of Medicine
  • 2003.09—2006.06 Doctor of Medicine: Huazhong University of Science and Technology Tongji Medical College
  • Jiangsu Province Six Talent Peaks
  • Nanjing Young and Middle-aged Industry Technology Discipline Leader
  • 1993.07—2008.7 - Jianghan University School of Medicine - Assistant, Lecturer, Associate Professor
  • 2006.11—2008.7 - Nanjing Military Region General Hospital - Postdoctoral Researcher
  • 2008.7—2020.5 - Nanjing Drum Tower Hospital - Head of Molecular Pathology Diagnostic Center
  • 2012.10—2020.5 - Nanjing Multi-center Sample Bank - Head
  • 2013.12—2015.1 - MD Anderson Cancer Center - Senior Visiting Scholar
  • 2014—2020.5 - Nanjing Drum Tower Hospital - Deputy Director
  • 2020.5—Present - First Affiliated Hospital of USTC (Anhui Provincial Hospital) - Director of Molecular Pathology Specialty
  • Medical New Technology Introduction Award (2019): Jiangsu Provincial Health Commission, Second Prize
  • Jiangsu Province Six Talent Peaks (2016): Jiangsu Provincial Party Committee Organization Department, Jiangsu Provincial Human Resources and Social Security Department, Jiangsu Provincial Department of Finance, Twelfth Batch of High-level Talents
  • PLA Medical Achievement Award (2010): General Logistics Department of the People's Liberation Army, Third Prize
  • Hubei Province 12th Excellent Academic Paper in Natural Science (2008): Hubei Provincial Science and Technology Association, First Prize
Early Tumor Biomarker Research
Early Tumor Microenvironment Research
Molecular Diagnosis of Tumor Biomarkers
  • Differential Expression and Prognostic Correlation of Immune Related Factors Between Right and Left Side Colorectal Cancer, Yue Hu, Jie Ding, Chengjiang Wu, Hong Gao, Meiling Ge, Qixiang Shao, Yanhong Liu, Qing Ye, 2022
  • The Diagnostic Potential of SHOX2 and RASSF1A DNA Methylation in Early Lung Adenocarcinoma, Hong Gao, Jun Yang, Lu He, Wei Wang, Yanhong Liu, Yue Hu, Meiling Ge, Jie Ding, Qing Ye, 2022
  • Longitudinal genomic alternations and clonal dynamics analysis of primary malignant melanoma of the esophagus, Jingjing Li, Wenyan Guan, Wei Ren, Ziyao Liu, Hongyan Wu, Yiqiang Chen, Siyuan Liu, Xiangming Quan, Zuoquan Yang, Chong Jiang, Jian He, Xiao Xiao, Qing Ye, 2022
  • Choline Kinase Alpha Is a Novel Transcriptional Target of the Brg1 in Hepatocyte: Implication in Liver Regeneration, Ming Kong, Wenhui Dong, Huihui Xu, Zhiwen Fan, Xiulian Miao, Yan Guo, Chengping Li, Qing Ye, Yutong Wang, Yong Xu, 2021
  • Typing FGFR2 translocation determines the response to targeted therapy of intrahepatic cholangiocarcinomas, Xiaohong Pu, Qing Ye, Jing Cai, Xin Yang, Yao Fu, Xiangshan Fan, Hongyan Wu, Jun Chen, Yudong Qiu, Shen Yue, 2021
  • Development and Clinical Validation of a 90-Gene Expression Assay for Identifying Tumor Tissue Origin, Qing Ye, Qifeng Wang, Peng Qi, Jinying Chen, Yifeng Sun, Shichai Jin, Wanli Ren, Chengshu Chen, Mei Liu, Midie Xu, Gang Ji, Jun Yang, Ling Nie, Qinghua Xu, Deshuang Huang, Xiang Du, Xiaoyan Zhou, 2020
Biomarkers Tumor Early Detection Cancer Diagnosis Molecular Research Oncology Microenvironment Pathology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.